Ardent Health (ARDT) Projected to Post Earnings on Wednesday

by · The Cerbat Gem

Ardent Health (NYSE:ARDT – Get Free Report) is expected to announce its Q3 2025 results after the market closes on Wednesday, November 12th. Analysts expect Ardent Health to post earnings of $0.42 per share and revenue of $1.5460 billion for the quarter. Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 13, 2025 at 9:00 AM ET.

Ardent Health Stock Down 5.2%

ARDT opened at $13.65 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. The stock’s fifty day moving average is $13.90 and its 200-day moving average is $13.38. Ardent Health has a one year low of $10.10 and a one year high of $17.95. The company has a market capitalization of $1.95 billion, a PE ratio of 7.54, a P/E/G ratio of 6.37 and a beta of 0.44.

Wall Street Analyst Weigh In

ARDT has been the topic of a number of recent research reports. KeyCorp lowered their target price on Ardent Health from $24.00 to $20.00 and set an “overweight” rating on the stock in a research note on Thursday, August 7th. Weiss Ratings upgraded Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Bank of America lowered shares of Ardent Health from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th. Wall Street Zen upgraded Ardent Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Finally, The Goldman Sachs Group began coverage on Ardent Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $19.00 target price for the company. Nine equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $19.30.

Check Out Our Latest Report on ARDT

Institutional Investors Weigh In On Ardent Health

A number of large investors have recently added to or reduced their stakes in ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after purchasing an additional 7,182 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares during the period. Jane Street Group LLC raised its holdings in Ardent Health by 235.1% during the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock worth $790,000 after purchasing an additional 40,318 shares during the last quarter. Acadian Asset Management LLC raised its position in shares of Ardent Health by 574.9% in the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock worth $550,000 after acquiring an additional 34,276 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Ardent Health by 0.6% in the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after buying an additional 1,769 shares during the period.

About Ardent Health

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Further Reading